Edition:
United States

Chiome Bioscience Inc (4583.T)

4583.T on Tokyo Stock Exchange

550JPY
22 Jul 2016
Change (% chg)

-- (--)
Prev Close
¥550
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
963,694
52-wk High
¥1,042
52-wk Low
¥430

4583.T

Chart for 4583.T

About

Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in three business segments. The Drug Discovery Alliance segment is engaged in the research and development of antibodies which aims at the development of... (more)
No analyst recommendations are available for 4583.T.

Overall

Beta: 2.70
Market Cap(Mil.): ¥12,345.03
Shares Outstanding(Mil.): 22.45
Dividend: --
Yield (%): --

Financials

  4583.T Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -55.99 -- --
ROI: -24.64 -5.86 14.35
ROE: -25.11 -4.70 15.56

BRIEF-Chiome Bioscience to get patent license from New Zealand

* Says New Zealand to grant patent license for ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO

Jun 02 2016

BRIEF-Chiome Bioscience gets patent license

* Says it gets patent license in Europe for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL

May 25 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.